알츠하이머 치매의 바이오마커-뇌영상 연구를 중심으로

키워드

참고문헌 (79)

1. Braak H, "Neuropathological stageing of Alzheimer-related changes", Acta Neuropathol, 82, pp.239~259 (1991)
2. Schmitt FA, "“Preclinical” AD revisited: neuropathology of cognitively normal older adults", Neurology, 55, pp.70~376 (2000)
3. GÓmez-Isla T, "Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer’s disease", J Neurosci, 16, pp.4491~4500 (1996)
4. Price JL, "Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease", Arch Neurol, 58, pp.1395~1402 (2001)
5. Jobst KA, "Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer’s disease", J Neurol Neurosurg Psychiatry, 55, pp.190~194 (1992)
6. De Leon MJ, "Frequency of hippocampal formation atrophy in normal aging and Alzheimer’s disease", Neurobiol Aging, 18, pp.1~11 (1997)
7. Frisoni GB, "Structural imaging in the clinical diagnosis of Alzheimer’s disease: problems and tools", J Neurol Neurosurg Psychiatry, 70, pp.711~718 (2001)
8. Scheltens P, "Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion", Lancet Neurol, 1, pp.13~21 (2002)
9. Bosscher L, "MRI of the temporal lobe. Evidence based dementia" (2001), Blackwell
10. Fotenos AF, "Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD", Neurology, 64, pp.1032~1039 (2005)
11. Thompson PM, "Dynamics of gray matter loss in Alzheimer’s disease", J Neurosci, 23, pp.994~1005 (2003)
12. Carlson NE, "Trajectories of brain loss in aging and the development of cognitive impairment", Neurology, 70, pp.828~833 (2008)
13. Whitwell JL, "Comparisons between Alzheimer disease, frontotemporal lobar degeneration, and normal aging with brain mapping", Top Magn Reson Imaging, 16, pp.409~425 (2005)
14. Barnes J, "Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration", Arch Neurol, 63, pp.1434~1439 (2006)
15. Jack CR Jr, "Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment", Neurology, 52, pp.1397~1403 (1999)
16. Wang PN, "Prediction of Alzheimer’s disease in mild cognitive impairment: a prospective study in Taiwan", Neurobiol Aging, 27, pp.1797~1806 (2006)
17. Ewers M, "Multicenter assessment of reliability of cranial MRI", Neurobiol Aging, 27, pp.1051~1059 (2006)
18. Jack CR Jr, "Rate of medial temporal lobe atrophy in typical aging and Alzheimer’s disease", Neurology, 51, pp.993~999 (1998)
19. Laakso MP, "Hippocampus in Alzheimer’s disease: a 3-year follow-up MRI study", Biol Psychiatry, 47, pp.557~561 (2000)
20. Krasuski JS, "Volumes of medial temporal lobe structures in patients with Alzheimer’s disease and mild cognitive impairment (and in healthy controls)", Biol Psychiatry, 43, pp.60~68 (1998)
21. Pennanen C, "Hippocampus and entorhinal cortex in mild cognitive impairment and early AD", Neurobiol Aging, 25, pp.303~310 (2004)
22. Teipel SJ, "Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI", J Neurol, 253, pp.794~800 (2006)
23. Xu Y, "Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD", Neurology, 54, pp.1760~1767 (2000)
24. Du AT, "Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease", J Neurol Neurosurg Psychiatry, 71, pp.441~447 (2001)
25. Ashburner J, "Voxel-based morphometry--the methods", Neuroimage, 11, pp.805~821 (2000)
26. Baron JC, "In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer’s disease", Neuroimage, 14, pp.298~309 (2001)
27. Busatto GF, "A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer’s disease", Neurobiol Aging, 24, pp.221~231 (2003)
28. Chételat G, "Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment", Neuroreport, 13, pp.1939~1943 (2002)
29. Pennanen C, "A voxel based morphometry study on mild cognitive impairment", J Neurol Neurosurg Psychiatry, 76, pp.11~14 (2005)
30. Teipel SJ, "Age-related cortical grey matter reductions in non-demented Down’s syndrome adults determined by MRI with voxelbased morphometry", Brain, 127, pp.811~824 (2004)
31. Teipel SJ, "Neuroanatomy of Down syndrome in vivo: a model of preclinical Alzheimer’s disease", Behav Genet, 36, pp.405~415 (2006)
32. Teipel SJ, "Multivariate deformation-based analysis of brain atrophy to predict Alzheimer’s disease in mild cognitive impairment", Neuroimage, 38, pp.13~24 (2007)
33. Lerch JP, "Focal decline of cortical thickness in Alzheimer’s disease identified by computational neuroanatomy", Cereb Cortex, 15, pp.995~1001 (2005)
34. Lerch JP, "Automated cortical thickness measurements from MRI can accurately separate Alzheimer’s patients from normal elderly controls", Neurobiol Aging, 29, pp.23~30 (2008)
35. Celone KA, "Alterations in memory networks in mild cognitive impairment and Alzheimer’s disease: an independent component analysis", J Neurosci, 26, pp.10222~10231 (2006)
36. Greicius MD, "Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI", Proc Natl Acad Sci U S A, 101, pp.4637~4642 (2004)
37. Rombouts SA, "Altered resting state networks in mild cognitive impairment and mild Alzheimer’s disease: an fMRI study", Hum Brain Mapp, 26, pp.231~239 (2005)
38. Bokde AL, "Functional connectivity of the fusiform gyrus during a facematching task in subjects with mild cognitive impairment", Brain, 129, pp.1113~1124 (2006)
39. Horwitz B, "Investigating the neural basis for functional and effective connectivity. Application to fMRI", Philos Trans R Soc Lond B Biol Sci, 360, pp.1093~1108 (2005)
40. Stahl R, "White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques", Radiology, 243, pp.483~492 (2007)
41. Sydykova D, "Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer’s disease: a diffusion tensor imaging and voxel-based morphometry study", Cereb Cortex, 17, pp.2276~2282 (2007)
42. Teipel SJ, "Multivariate network analysis of fiber tract integrity in Alzheimer’s disease", Neuroimage, 34, pp.985~995 (2007)
43. Moffett JR, "NAcetylaspartate in the CNS: from neurodiagnostics to neurobiology", Prog Neurobiol, 81, pp.89~131 (2007)
44. Kantarci K, "1H magnetic resonance spectroscopy in dementia", Br J Radiol, 80, pp.146~152 (2007)
45. Burns A, "The investigation of Alzheimer’s disease with single photon emission tomography", J Neurol Neurosurg Psychiatry, 52, pp.248~253 (1989)
46. Hunter R, "The pattern of function-related regional cerebral blood flow investigated by single photon emission tomography with 99mTc-HMPAO in patients with presenile Alzheimer’s disease and Korsakoff’s psychosis", Psychol Med, 19, pp.847~855 (1989)
47. Jobst KA, "Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer’s disease", J Neurol Neurosurg Psychiatry, 55, pp.190~194 (1992)
48. Harris GJ, "Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine", AJNR Am J Neuroradiol, 19, pp.1727~1732 (1998)
49. Huang C, "Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT", Neurobiol Aging, 28, pp.1062~1069 (2007)
50. Huang C, "Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment", Neuroimage, 19, pp.1137~1144 (2003)
51. Borroni B, "Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD", Neurobiol Aging, 27, pp.24~31 (2006)
52. Hirao K, "The prediction of rapid conversion to Alzheimer’s disease in mild cognitive impairment using regional cerebral blood flow SPECT", Neuroimage, 28, pp.1014~1021 (2005)
53. Kogure D, "Longitudinal evaluation of early Alzheimer’s disease using brain perfusion SPECT", J Nucl Med, 41, pp.1155~1162 (2000)
54. Hoffman JM, "FDG PET imaging in patients with pathologically verified dementia", J Nucl Med, 41, pp.1920~1928 (2000)
55. Sakamoto S, "Differences in cerebral metabolic impairment between early and late onset types of Alzheimer’s disease", J Neurol Sci, 200, pp.27~32 (2002)
56. Minoshima S, "Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease", Ann Neurol, 42, pp.85~94 (1997)
57. Nestor PJ, "Limbic hypometabolism in Alzheimer’s disease and mild cognitive impairment", Ann Neurol, 54, pp.343~351 (2003)
58. Becker JT, "Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer’s disease", Neurology, 46, pp.692~700 (1996)
59. Moulin CJ, "Brain function during multi-trial learning in mild cognitive impairment: a PET activation study", Brain Res, 1136, pp.132~141 (2007)
60. Mosconi L, "Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease. FDG-PET studies in MCI and AD", Eur J Nucl Med Mol Imaging, 32, pp.486~510 (2005)
61. Mosconi L, "Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementias", J Nucl Med, 49, pp.390~398 (2008)
62. Mosconi L, "Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer’s disease using FDG-PET", Eur J Nucl Med Mol Imaging, 33, pp.210~221 (2006)
63. Foster NL, "Cortical abnormalities in Alzheimer’s disease", Ann Neurol, 16, pp.649~654 (1984)
64. Mosconi L, "Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer’s disease", J Nucl Med, 47, pp.1778~1786 (2006)
65. Reiman EM, "Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia", Proc Natl Acad Sci U S A, 101, pp.284~289 (2004)
66. Mosconi L, "Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints", Biol Psychiatry, 63, pp.609~618 (2008)
67. Drzezga A, "Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer’s disease: a PET follow-up study", Eur J Nucl Med Mol Imaging, 30, pp.1104~1113 (2003)
68. Mosconi L, "Maternal family history of Alzheimer’s disease predisposes to reduced brain glucose metabolism", Proc Natl Acad Sci U S A, 104, pp.19067~19072 (2007)
69. Klunk WE, "Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B", Ann Neurol, 55, pp.306~319 (2004)
70. PIB uptake in Alzheimer disease, "Neurology", 2006, 1575~1580
71. PIB in a nondemented population: potential antecedent marker of Alzheimer disease, "Neurology", 2006, 446~452
72. Lockhart A, "PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptiderelated cerebral amyloidosis", Brain, 130, pp.2607~2615 (2007)
73. Klunk WE, "Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees", J Neurosci, 27, pp.6174~6184 (2007)
74. Reiman EM, "Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer’s disease", Proc Natl Acad Sci U S A, 106, pp.6820~6825 (2009)
75. Wolk DA, "Amyloid imaging in mild cognitive impairment subtypes", Ann Neurol, 65, pp.557~568 (2009)
76. 김병채, "Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease", EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 35(12), pp.2169~2181, SPRINGER
77. Okello A, "Turkheimer FE, Någren K, et al. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study", Neurology, 73, pp.754~760 (2009)
78. Morris JC, "Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease", Arch Neurol, 66, pp.1469~1475 (2009)
79. Small GW, "PET of brain amyloid and tau in mild cognitive impairment", N Engl J Med, 355, pp.2652~2663 (2006)

관련 논문AI추천